Preparing for the Next MHRA & EMA Inspection Cycle

2026-05-20T11:35:17+01:00News|

Regulatory inspections remain one of the most important aspects of pharmaceutical quality assurance. As the pharmaceutical industry continues to evolve through digital transformation, global supply chain complexity, and increasing regulatory expectations, organisations must ensure they are consistently inspection-ready. Both the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) and the European Medicines Agency (EMA)